Jun Xue
Impact in
-
- Electrospun Nanofibers in Biomedical Applications
-
- Systemic Sclerosis and Related Diseases
Papers in
-
- Microbial Natural Products and Biosynthesis 2
- Co-authors
- Ying ZhengJonathan HimmelfarbRyan J. NagaoJin XuKimberly A. MuczynskiTheo K. BammlerYoon Jung ChoiJames W. MacDonald
- Journals
- Frontiers in Immunology (2 papers)iScience (1 paper)ACS Biomaterials Science & Engineering (1 paper)Journal of Cancer (1 paper)Neurobiology of Disease (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jun Xue
28 papers receiving 659 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 70
- Pathology and Forensic Medicine 90
- Immunology 93
- Nephrology 31
- Molecular Biology 288
Countries citing papers authored by Jun Xue
This map shows the geographic impact of Jun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xue more than expected).
Fields of papers citing papers by Jun Xue
This network shows the impact of papers produced by Jun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xue. The network helps show where Jun Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 16 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 186 | |
| 13 | 2016 | 74 | |
| 14 | 2015 | 75 | |
| 15 | 2012 | 6 | |
| 16 | 2011 | 35 | |
| 17 | Characteristics of Human adipose tissue-derived stem cells and the ability of differentiate into endothelial cells in vitro | 2009 | 1 |
| 18 | 2008 | 102 | |
| 19 | 2007 | 18 | |
| 20 | 2000 | 3 |
About Jun Xue
Jun Xue is a scholar working on Transplantation, Pharmacology, Oncology, Neurology and Immunology, having authored 29 papers that have together received 662 indexed citations. Recurring topics across this work include Renal and related cancers (6 papers), Reproductive Biology and Fertility (4 papers), Pluripotent Stem Cells Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Biomaterials (70 citations), Pathology and Forensic Medicine (90 citations), Immunology (93 citations), Nephrology (31 citations) and Molecular Biology (288 citations). Jun Xue has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ying Zheng, Jonathan Himmelfarb, Ryan J. Nagao, Jin Xu, Kimberly A. Muczynski, Theo K. Bammler, Yoon Jung Choi, James W. MacDonald, Stephen M. Schwartz and Raluca Marcu. Their work appears in journals such as Frontiers in Immunology, iScience, ACS Biomaterials Science & Engineering, Journal of Cancer and Neurobiology of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.